Tech Center 1600 • Art Units: 1600 1635 1636 1674
This examiner grants 47% of resolved cases
Ruth Sophia Arieti is an examiner in Tech Center 1600 with 89 resolved cases. Her allowance rate is 46.1 percent. This 46.1 percent rate indicates the frequency of granted patents among the 89 resolved cases. Practitioners can use these figures to evaluate the prosecution environment in this tech center. The record of 89 resolved cases provides a basis for analyzing the examiner's past actions and success rates.
The interview lift is 70.7 percent, which is a statistic that shows the change in allowance probability following an interview. This 70.7 percent lift is a metric for developing a strategy. The median days to allowance is 1239, providing a benchmark for the time required to reach a grant. This 1239-day median is a data point for managing expectations. These figures from Tech Center 1600 serve as the basis for understanding the examiner's historical performance and the duration of the prosecution cycle.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17836265 | Modified Guide RNAs for Gene Editing | Final Rejection | Intellia Therapeutics, Inc. |
| 16999759 | O-METHYL RICH FULLY STABILIZED OLIGONUCLEOTIDES | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 18558886 | USE OF CHEMICAL EPIGENETIC MODIFIERS TO MODULATE GENE EXPRESSION FROM VECTORS | Non-Final OA | The University of North Carolina at Chapel Hill |
| 18310891 | ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES, COMPOSITIONS, AND USES THEREOF | Non-Final OA | Massachusetts Institute of Technology |
| 18283699 | TARGETING MULTIPLE T CELL TYPES USING SPHERICAL NUCLEIC ACID VACCINE ARCHITECTURE | Non-Final OA | NORTHWESTERN UNIVERSITY |
| 18248974 | RNA COMPOSITIONS AND METHODS FOR INHIBITING LIPOPROTEIN(A) | Final Rejection | SANOFI |
| 18037029 | SUPPRESSING HIPPO SIGNALING IN THE STEM CELL NICHE PROMOTES SKELETAL MUSCLE REGENERATION | Final Rejection | Texas Heart Institute |
| 17127773 | METHODS AND MATERIALS FOR CLONING FUNCTIONAL T CELL RECEPTORS FROM SINGLE T CELLS | Non-Final OA | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 18033049 | DUAL AAV VECTOR-MEDIATED DELETION OF LARGE MUTATIONAL HOTSPOT FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | Non-Final OA | Duke University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy